CUMERLATO, MICHELA
CUMERLATO, MICHELA
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
A Potential Role of RUNX2- RUNT Domain in Modulating the Expression of Genes Involved in Bone Metastases: An In Vitro Study with Melanoma Cells
2020-01-01 Deiana M.; Dalle Carbonare L.; Serena M.; Cheri S.; Mutascio S.; Gandini A.; Innamorati G.; Lorenzi P.; Cumerlato M.; Bertacco J.; Antoniazzi F.; Romanelli M.G.; Mottes M.; Zipeto D.; Valenti M.T.
Bedaquiline amplifies proteasome inhibitor efficacy and overcomes resistance in multiple myeloma
2026-01-01 Cumerlato, Michela; Maccagno, Monica; Labrador, María; Luciano, Beatrice; Mereu, Elisabetta; Porro, Mariangela; Bandini, Cecilia; Furlan, Mattia; Maisano, Domenico; D'Agostino, Mattia; Larocca, Alessandra; Gay, Francesca; Tamburrini, Annalaura; Anselmi, Francesca; Porporato, Paolo Ettore; Oliviero, Salvatore; Bruno, Benedetto; Morelli, Eugenio; Munshi, Nikhil; Piva, Roberto
Biomimetic mesoporous vectors enabling the efficient inhibition of wild-type isocitrate dehydrogenase in multiple myeloma cells
2021-01-01 Cauda V.; Xu T.T.; Nunes I.; Mereu E.; Villata S.; Bergaggio E.; Labrador M.; Limongi T.; Susa F.; Chiodoni A.; Cumerlato M.; Rosso G.; Stefania R.; Piva R.
Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma
2024-01-01 Noemi Puccio; Gloria Manzotti; Mereu E; Torricelli F; Ronchetti D; Cumerlato M; Craparotta I; Di Rito L; Bolis M; Traini V; Manicardi V; Fragliasso V; Torrente Y; Amodio N; Bolli N; Taiana E; Ciarrocchi A; Piva R; Neri A
CRISPR activation screen identifies MDM2 as a modulator of proteasome inhibitor resistance in multiple myeloma
2023-01-01 María Labrador Granados, Sara Cozzubbo, Mariangela Porro, Elisabetta Mereu, Tina Paradzik, Cecilia Bandini, Michela Cumerlato, Benedetta Donati, Veronica Manicardi, Domenica Ronchetti, Alessia Ciarrocchi, Antonino Neri.
CRISPR activation screen identifies novel drivers of proteasome inhibitor resistance in multiple myeloma.
2025-01-01 Mariangela Porro, María Labrador Granados, Elisabetta Mereu, Michela Cumerlato, Benedetta Donati, Veronica Manicardi, Domenica Ronchetti, Alessia Ciarrocchi, Antonino Neri, Roberto Piva.
CRISPR-Cas13d functional transcriptomics reveals widespread isoform-selective cancer dependencies on lncRNAs
2025-01-01 Morelli, Eugenio; Aktas Samur, Anil; Maisano, Domenico; Gao, Claire; Favasuli, Vanessa Katia; Papaioannou, Dimitrios; De Nola, Giovanni; Henninger, Jonathan E; Liu, Na; Turi, Marcello; Folino, Pietro; Vreux, Laure; Cumerlato, Michela; Chen, Liang; Aifantis, Iannis; Fulciniti, Mariateresa; Anderson, Kenneth C.; Lytton-Jean, Abigail KR; Gulla, Annamaria; Young, Richard; Samur, Mehmet K.; Munshi, Nikhil C.
Diving on the Surface of a Functional Metal Oxide through a Multiscale Exploration of Drug-Nanocrystal Interactions
2025-01-01 Percivalle N.M.; Bassila J.B.; Piccinini A.; Cumerlato M.; Porro M.; Trouki C.; Monti S.; Barcaro G.; Bochicchio D.; Piva R.; Rondelli V.; Rossi G.; Cauda V.
Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines
2023-01-01 Mereu, Elisabetta; Abbo, Damiano; Paradzik, Tina; Cumerlato, Michela; Bandini, Cecilia; Labrador, Maria; Maccagno, Monica; Ronchetti, Domenica; Manicardi, Veronica; Neri, Antonino; Piva, Roberto
Functional screenings converge on MDM2 as a modulator of proteasome inhibitor resistance in multiple myeloma
2022-01-01 María Labrador Granados, Sara Cozzubbo, Mariangela Porro, Mereu E., Paradzik T., Cecilia Bandini, Cumerlato M., Donati B., Manicardi V., Ronchetti D., Ciarrocchi A., Antonino Neri, Roberto Piva
Genetic and Drug Screenings Revealed New Synthetic Lethal Interactions to Proteasome Inhibitors in Multiple Myeloma
2024-01-01 Michela Cumerlato, Elisabetta Mereu, Cecilia Bandini, Tina Paradzik, Damiano Abbo, María Labrador Granados, Monica Maccagno, Mattia D’Agostino, Antonino Neri, Roberto Piva.
Harnessing Synthetic Lethal Interactions in Hematological Malignancies: Novel Therapeutic Approaches to Overcome Drug Resistance
2025-04-02
LSD1 inhibition increases DNA damage and enhances proteasome inhibition sensitivity in multiple myeloma and other B-cell malignancies
2022-01-01 Cecilia Bandini, María Labrador Granados, Mereu E., Paradzik T., Cumerlato M., Federico Oreglia, Giada Cipollina, Lorenzo Prever, Sauta E., Veronica Manicardi, Elisa Taiana, Domenica Ronchetti, Ferrero S., Francesca Gay, Alessandra Larocca, Giorgio Merlo, Alessia Ciarrocchi, Antonino Neri, Roberto Piva
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma
2023-01-01 Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Labrador, Maria; Maccagno, Monica; Cumerlato, Michela; Oreglia, Federico; Prever, Lorenzo; Manicardi, Veronica; Taiana, Elisa; Ronchetti, Domenica; D'Agostino, Mattia; Gay, Francesca; Larocca, Alessandra; Besse, Lenka; Merlo, Giorgio Roberto; Hirsch, Emilio; Ciarrocchi, Alessia; Inghirami, Giorgio; Neri, Antonino; Piva, Roberto
MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma
2026-01-01 Labrador, María; Cozzubbo, Sara; Porro, Mariangela; Cumerlato, Michela; Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Donati, Benedetta; Manicardi, Veronica; Ronchetti, Domenica; D'Agostino, Mattia; Larocca, Alessandra; Gay, Francesca; Bruno, Benedetto; Ciarrocchi, Alessia; Chatr-Aryamontri, Andrew; Neri, Antonino; Morelli, Eugenio; Piva, Roberto
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Potential Role of RUNX2- RUNT Domain in Modulating the Expression of Genes Involved in Bone Metastases: An In Vitro Study with Melanoma Cells | 2020 | Deiana M.; Dalle Carbonare L.; Serena M.; Cheri S.; Mutascio S.; Gandini A.; Innamorati G.; Lorenzi P.; Cumerlato M.; Bertacco J.; Antoniazzi F.; Romanelli M.G.; Mottes M.; Zipeto D.; Valenti M.T. | |
| Bedaquiline amplifies proteasome inhibitor efficacy and overcomes resistance in multiple myeloma | 2026 | Cumerlato, Michela; Maccagno, Monica; Labrador, María; Luciano, Beatrice; Mereu, Elisabetta; Porro, Mariangela; Bandini, Cecilia; Furlan, Mattia; Maisano, Domenico; D'Agostino, Mattia; Larocca, Alessandra; Gay, Francesca; Tamburrini, Annalaura; Anselmi, Francesca; Porporato, Paolo Ettore; Oliviero, Salvatore; Bruno, Benedetto; Morelli, Eugenio; Munshi, Nikhil; Piva, Roberto | |
| Biomimetic mesoporous vectors enabling the efficient inhibition of wild-type isocitrate dehydrogenase in multiple myeloma cells | 2021 | Cauda V.; Xu T.T.; Nunes I.; Mereu E.; Villata S.; Bergaggio E.; Labrador M.; Limongi T.; Susa F.; Chiodoni A.; Cumerlato M.; Rosso G.; Stefania R.; Piva R. | |
| Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma | 2024 | Noemi Puccio; Gloria Manzotti; Mereu E; Torricelli F; Ronchetti D; Cumerlato M; Craparotta I; Di Rito L; Bolis M; Traini V; Manicardi V; Fragliasso V; Torrente Y; Amodio N; Bolli N; Taiana E; Ciarrocchi A; Piva R; Neri A | |
| CRISPR activation screen identifies MDM2 as a modulator of proteasome inhibitor resistance in multiple myeloma | 2023 | María Labrador Granados, Sara Cozzubbo, Mariangela Porro, Elisabetta Mereu, Tina Paradzik, Cecilia Bandini, Michela Cumerlato, Benedetta Donati, Veronica Manicardi, Domenica Ronchetti, Alessia Ciarrocchi, Antonino Neri. | |
| CRISPR activation screen identifies novel drivers of proteasome inhibitor resistance in multiple myeloma. | 2025 | Mariangela Porro, María Labrador Granados, Elisabetta Mereu, Michela Cumerlato, Benedetta Donati, Veronica Manicardi, Domenica Ronchetti, Alessia Ciarrocchi, Antonino Neri, Roberto Piva. | |
| CRISPR-Cas13d functional transcriptomics reveals widespread isoform-selective cancer dependencies on lncRNAs | 2025 | Morelli, Eugenio; Aktas Samur, Anil; Maisano, Domenico; Gao, Claire; Favasuli, Vanessa Katia; Papaioannou, Dimitrios; De Nola, Giovanni; Henninger, Jonathan E; Liu, Na; Turi, Marcello; Folino, Pietro; Vreux, Laure; Cumerlato, Michela; Chen, Liang; Aifantis, Iannis; Fulciniti, Mariateresa; Anderson, Kenneth C.; Lytton-Jean, Abigail KR; Gulla, Annamaria; Young, Richard; Samur, Mehmet K.; Munshi, Nikhil C. | |
| Diving on the Surface of a Functional Metal Oxide through a Multiscale Exploration of Drug-Nanocrystal Interactions | 2025 | Percivalle N.M.; Bassila J.B.; Piccinini A.; Cumerlato M.; Porro M.; Trouki C.; Monti S.; Barcaro G.; Bochicchio D.; Piva R.; Rondelli V.; Rossi G.; Cauda V. | |
| Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines | 2023 | Mereu, Elisabetta; Abbo, Damiano; Paradzik, Tina; Cumerlato, Michela; Bandini, Cecilia; Labrador, Maria; Maccagno, Monica; Ronchetti, Domenica; Manicardi, Veronica; Neri, Antonino; Piva, Roberto | |
| Functional screenings converge on MDM2 as a modulator of proteasome inhibitor resistance in multiple myeloma | 2022 | María Labrador Granados, Sara Cozzubbo, Mariangela Porro, Mereu E., Paradzik T., Cecilia Bandini, Cumerlato M., Donati B., Manicardi V., Ronchetti D., Ciarrocchi A., Antonino Neri, Roberto Piva | |
| Genetic and Drug Screenings Revealed New Synthetic Lethal Interactions to Proteasome Inhibitors in Multiple Myeloma | 2024 | Michela Cumerlato, Elisabetta Mereu, Cecilia Bandini, Tina Paradzik, Damiano Abbo, María Labrador Granados, Monica Maccagno, Mattia D’Agostino, Antonino Neri, Roberto Piva. | |
| Harnessing Synthetic Lethal Interactions in Hematological Malignancies: Novel Therapeutic Approaches to Overcome Drug Resistance | 2025 | - | |
| LSD1 inhibition increases DNA damage and enhances proteasome inhibition sensitivity in multiple myeloma and other B-cell malignancies | 2022 | Cecilia Bandini, María Labrador Granados, Mereu E., Paradzik T., Cumerlato M., Federico Oreglia, Giada Cipollina, Lorenzo Prever, Sauta E., Veronica Manicardi, Elisa Taiana, Domenica Ronchetti, Ferrero S., Francesca Gay, Alessandra Larocca, Giorgio Merlo, Alessia Ciarrocchi, Antonino Neri, Roberto Piva | |
| Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma | 2023 | Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Labrador, Maria; Maccagno, Monica; Cumerlato, Michela; Oreglia, Federico; Prever, Lorenzo; Manicardi, Veronica; Taiana, Elisa; Ronchetti, Domenica; D'Agostino, Mattia; Gay, Francesca; Larocca, Alessandra; Besse, Lenka; Merlo, Giorgio Roberto; Hirsch, Emilio; Ciarrocchi, Alessia; Inghirami, Giorgio; Neri, Antonino; Piva, Roberto | |
| MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma | 2026 | Labrador, María; Cozzubbo, Sara; Porro, Mariangela; Cumerlato, Michela; Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Donati, Benedetta; Manicardi, Veronica; Ronchetti, Domenica; D'Agostino, Mattia; Larocca, Alessandra; Gay, Francesca; Bruno, Benedetto; Ciarrocchi, Alessia; Chatr-Aryamontri, Andrew; Neri, Antonino; Morelli, Eugenio; Piva, Roberto |